Drugs Made In America Acquisition (DMAA) Debt Ratio (2024 - 2026)
Drugs Made In America Acquisition's (DMAA) quarterly Debt Ratio came in at 0.0 in Q2 2026, up 355.41% quarter-over-quarter from 0.0 in Q1 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMAA) Debt Ratio (2024 - 2026) Analysis & Trends
Drugs Made In America Acquisition (DMAA) has reported Debt Ratio for 3 consecutive years, with 0.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Debt Ratio changed N/A year-over-year to 0.0; the trailing twelve-month figure through Jun 2026 stood at 0.0 (changed N/A YoY), and the FY2024 full-year result was 2.4, changed N/A from the prior year.
- Debt Ratio rose to 0.0 in Q2 2026 per DMAA's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 2.4 in Q4 2024 and bottomed at 0.0 in Q1 2025.
- Historically, Debt Ratio has averaged 0.8 across 3 years, with a median of 0.0 in 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Blackstone | 102.43 Bn | 104.87 Bn | - | 0.26 |
| 2 | Kkr | 96.71 Bn | -180.36 Bn | - | - |
| 3 | Brookfield Asset Management | 80.84 Bn | 80.57 Bn | - | 0.17 |
| 4 | Apollo Global Management | 76.99 Bn | 72.09 Bn | 10.54 Bn | 0.03 |
| 5 | Wheaton Precious Metals | 70.37 Bn | 70.27 Bn | 687.86 Mn | 0.16 |
| 6 | Franco Nevada | 51.31 Bn | 49.77 Bn | 451.00 Mn | - |
| 7 | Ares Management | 50.50 Bn | 55.42 Bn | - | 0.15 |
| 8 | Brookfield | 37.98 Bn | 7.42 Bn | 19.38 Bn | 0.17 |
| 9 | Tpg | 20.58 Bn | 22.14 Bn | - | 0.17 |
| 10 | Drugs Made In America Acquisition | 332.47 Mn | 332.47 Mn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 2.40 |